The Comparison Nobody Is Making Correctly
The publicly traded quantum sector has a valuation problem — and it cuts against conventional wisdom. Not because quantum companies are overvalued as a category, but because one of them appears to be significantly undervalued relative to the only metric that should matter in early-stage technology: actual revenue.
As of March 2026, four companies define the public quantum universe. IonQ trades at approximately $13.2 billion market cap against $130 million in trailing twelve-month revenue — a price-to-sales multiple of roughly 102×. D-Wave commands $7.0 billion against $24.6 million in TTM revenue, a 285× multiple. Rigetti, generating $7.1 million in trailing revenue, trades at approximately $5.9 billion — an 831× multiple that can only be justified by arguments about extreme future optionality.
Then there is Infleqtion (NYSE: INFQ). Market cap approximately $2.5 billion. Trailing twelve-month revenue approximately $29 million — the second-highest absolute revenue in the sector. P/S multiple: approximately 83×. The cheapest in the peer group, with the second-highest revenue. Source: S-4/A audited financials filed February 14, 2026; peer multiples from public filings.
The reason for the discount is not complicated: Infleqtion listed via SPAC on February 13, 2026. At time of writing, the company has three weeks of NYSE trading history. The SPAC discount is real. It is also temporary. And it has nothing to do with the underlying fundamentals.
The Revenue Is Field-Validated
The $29 million TTM figure is not lab revenue, grant income, or contract research disguised as commercial activity. The S-4/A filed February 14 contains audited financials confirming an approximately 80% two-year revenue CAGR. More importantly, the revenue traces to field deployments in genuinely demanding operational environments.
Three deployments are worth naming specifically. In October 2025, Infleqtion's Tiqker hardware was integrated into the New Zealand Navy's HMNZS Aotearoa for autonomous submarine navigation — GPS-free underwater positioning, one of the most technically demanding applications of precision timing hardware that exists outside a laboratory. In February 2026, the Quantum Corridor demonstration in Chicago synchronized a live 22-kilometer urban fiber network to 10-picosecond precision, validating commercial-grade timing performance in real telecommunications infrastructure. UK Ministry of Defence flight trials validated quantum sensing capability in a military aviation environment.
Any single one of these deployments would be the featured press release for IonQ or Rigetti. For Infleqtion, they are footnotes in a $300+ million self-reported pipeline. The technology is not a roadmap. It has been deployed in the field, in conditions that most quantum hardware developers have never attempted.
A note on the pipeline figure: the proxy defines this as "potential customers identified as sales targets not yet under contract" — the lowest tier of the sales funnel, not backlog. The funded backlog of approximately $50 million represents near-certainty revenue. The $300 million is an aspirational funnel that requires rigorous conversion analysis before being modeled.
The Coverage Gap That Creates the Opportunity
At time of writing, Infleqtion has exactly one institutional analyst covering it: Rosenblatt Securities. The SPAC quiet period expired March 10. Kevin Garrigan — Rosenblatt's quantum technology specialist, who held at least two management meetings ahead of listing — is widely expected to initiate coverage in the week of March 16. Rosenblatt's discounted revenue methodology, applying a 36.6× EV/Sales multiple to a 2030 revenue estimate of $100–120 million and discounting to present, produces a price target range of approximately $15–22 per share.
BTIG is the only other firm widely expected to initiate near-term. One disclosure worth making explicit: BTIG holds approximately 360,000 founder shares from underwriting compensation, subject to the same August 2026 lock-up as the SPAC sponsor. Their economic interest and their analytical recommendation point in the same direction. This conflict does not make their analysis wrong — it means it should be weighted accordingly.
JPMorgan, Citigroup, Needham, and Morgan Stanley Investment Management (through Counterpoint Global's PIPE participation) are all potential initiators. None have announced coverage as of this writing.
The historical pattern in small-cap deep tech is consistent: when the first institutional coverage initiates, it triggers a cascade of permission structures for institutional buyers who cannot hold uncovered names in their mandates. Valuation gaps of the magnitude visible in INFQ relative to IonQ and D-Wave have historically compressed within 6–12 months of initiation when the underlying revenue trajectory is intact.
The Counter-Argument
The discount is partially rational and anyone arguing otherwise is not being honest with their analysis. The single most important near-term risk is the lock-up expiry approximately August 12, 2026. At that date, approximately 152 million shares — roughly 70% of shares outstanding — become freely tradeable.
The most dangerous individual seller is the Churchill Capital/Klein sponsor vehicle: approximately 10.7 million shares at a cost basis of roughly $0.003 per share, confirmed in the 13D filing of February 18, 2026. Churchill/Klein are massively in the money at any price above a few cents and will sell at the first legal opportunity. Historical data on deep-tech SPAC lock-up expirations shows a median decline of 25–40% in the surrounding six-month window. The full structural analysis of the lock-up dynamics is in the lock-up analysis article — the August 2026 window deserves serious attention before sizing any position.
There is also a critical correction to a widely cited near-term catalyst: Infleqtion will not be added to the Russell 2000 at the June 2026 reconstitution. FTSE Russell applies a de-SPAC lock-up exclusion, and INFQ's lock-up expires after the April 30 rank date. Earliest possible inclusion is September 2026. The passive demand is real; the June 2026 timing assumption is not. Investors who built conviction around June 2026 Russell inclusion should revise their framework.
The Setup: Time Is on the Long Side
What makes the fundamental picture structurally different from most newly listed companies is the balance sheet. The S-4/A confirms approximately $550 million in cash post-close, against zero debt. At an annual cash burn rate of $21–33 million, Infleqtion has more than 15 years of runway at current spend levels. It does not need to dilute to fund operations. It does not need a commercial breakthrough in the next 12 months to maintain viability.
The valuation gap between INFQ at 83× P/S and its peer group is not a function of whether the technology works, whether the revenue is real, or whether the balance sheet is healthy. It is a function of three weeks of trading history, SPAC stigma, and zero institutional coverage. All three of those conditions are temporary. The $29 million in audited revenue growing at 80% CAGR is not.
Author holds a long position in INFQ. This is not investment advice.